快訊:香港加密货币先锋:批准首个比特币和以太坊现货交易所交易基金
香港成為第一個主要金融中心,批準比特幣和以太坊現貨交易所交易基金,開創性地在加密貨幣市場樹立了新的先例。香港證監會已經批準了行業領袖,包括華夏基金管理、國泰基金管理和Hashkey資本有限公司,同時Harvest全球投資也獲得了初步批準。這一戰略決定預計將鞏固香港作為金融創新中心的地位,特別是在蓬勃發展的數字資產領域。隨著這些提供直接加密貨幣認購的ETF的推出,香港將自己定位在促進主流加密貨幣采用和投資的前沿。市場對此做出了積極回應,比特幣和以太坊的價格在這一消息後出現了顯著上漲。這一重要發展不僅突顯了香港成為區域加密貨幣中心的雄心壯志,也預示著監管接受和投資者參與數字資產領域的重大飛躍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.